SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (1088)7/8/1997 9:52:00 PM
From: billkirn   of 1762
 
Margie: If IDPH follows the same path as AGPH, I would expcet it
to continue up thru July 25. If C2B8 gets approved, high volume
should follow allowing funds to take some profits. If C2B8
doesnt get approved, huge fall.
If IDPH reaches 30 by July 25, and approval, my guess it hits 20 soon after,
if no approval, my guess it hits 7-10 soon after.
Not a pretty picture for the short term, but a possibility. If it does
reach 30 before July 25, I will probably sell and wait for the dust to
settle.
Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News